186 related articles for article (PubMed ID: 2103495)
21. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins.
Duchrow M; Schlüter C; Key G; Kubbutat MH; Wohlenberg C; Flad HD; Gerdes J
Arch Immunol Ther Exp (Warsz); 1995; 43(2):117-21. PubMed ID: 8744726
[TBL] [Abstract][Full Text] [Related]
22. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
23. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.
Kreipe H; Heidebrecht HJ; Hansen S; Röhlk W; Kubbies M; Wacker HH; Tiemann M; Radzun HJ; Parwaresch R
Am J Pathol; 1993 Jan; 142(1):3-9. PubMed ID: 8093827
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
[TBL] [Abstract][Full Text] [Related]
25. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity.
Gonzalez-Moles MA; Caballero R; Rodriguez-Archilla A; Ruiz-Avila I; Bravo I
Acta Stomatol Belg; 1996 Dec; 93(4):159-65. PubMed ID: 9658636
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
[TBL] [Abstract][Full Text] [Related]
27. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
28. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
[TBL] [Abstract][Full Text] [Related]
29. [Ki-67 antigen, a cell cycle and tumor growth marker].
Seigneurin D; Guillaud P
Pathol Biol (Paris); 1991 Dec; 39(10):1020-8. PubMed ID: 1666669
[TBL] [Abstract][Full Text] [Related]
30. Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer.
Clark GM; Allred DC; Hilsenbeck SG; Chamness GC; Osborne CK; Jones D; Lee WH
Cancer Res; 1997 Dec; 57(24):5505-8. PubMed ID: 9407959
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
[TBL] [Abstract][Full Text] [Related]
32. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
34. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
Kunz J; Schmidt A
Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
[TBL] [Abstract][Full Text] [Related]
35. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.
Yu CC; Filipe MI
Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685
[TBL] [Abstract][Full Text] [Related]
36. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
[TBL] [Abstract][Full Text] [Related]
37. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma.
Drach J; Gattringer C; Glassl H; Schwarting R; Stein H; Huber H
Cytometry; 1989 Nov; 10(6):743-9. PubMed ID: 2684579
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity in non-Hodgkin's lymphomas and chronic lymphocytic leukemias as determined on cytological samples by Ki 67 monoclonal antibody.
Musto P; Melillo L; Lombardi G; Aieta M; Di Renzo N; Carotenuto M
Haematologica; 1990; 75(6):583-4. PubMed ID: 2098303
[No Abstract] [Full Text] [Related]
40. [Flow cytometric analysis of Ki-67 reactive antigen].
Murakami T; Sasaki K; Takahashi M
Nihon Rinsho; 1992 Oct; 50(10):2355-9. PubMed ID: 1280305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
